A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21350003

Clin. Cancer Res. 2011 May 15 17 10 3398-407

Download in:

View as

Triples

General Info

PMID
21350003